Loading...
Thrombopoietin receptor agonists: ten years later
The two thrombopoietin receptor agonists (TPO-RA), eltrombopag and romiplostim, were licensed in the US for treatment of immune thrombocytopenia (ITP) in 2008 and, since then, their use has progressively increased around the world; they are currently used in more than 100 countries. The six largest...
Saved in:
| Published in: | Haematologica |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Ferrata Storti Foundation
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6545830/ https://ncbi.nlm.nih.gov/pubmed/31073079 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.212845 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|